Congo vs Philippines: Share of people with HIV who receive antiretroviral therapy
Congo
34.0%
in 2024
Philippines
40.0%
in 2024
Congo rank
135th
Philippines rank
134th
Share of people with HIV who receive antiretroviral therapy over time
- Congo
- Philippines
How they compare
Philippines currently reports 40.0% against 34.0% in Congo, a difference of 6.0%.
That makes Philippines's figure about 1.2 times Congo's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Philippines ahead.
Congo ranks 135th and Philippines ranks 134th of 143 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Philippines in 2.
Head to head by decade
| Decade | Congo | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 1.4% | 2.3% | Congo |
| 2010s | 19.7% | 20.9% | 1.2% | Philippines |
| 2020s | 28.2% | 39.6% | 11.4% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Congo or Philippines?
- Philippines, at 40.0% against 34.0% in Congo as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Congo and Philippines?
- 6.0%, with Philippines ahead.
- How many years of comparable data are there for Congo and Philippines?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Philippines rank globally for share of people with hiv who receive antiretroviral therapy?
- Congo ranks 135th and Philippines ranks 134th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.